Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment
Crossref DOI link: https://doi.org/10.1371/journal.pone.0232597
Published Online: 2020-04-30
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Priest, Nicholas D.
Dauer, Lawrence T.
Hoel, David G. http://orcid.org/0000-0002-1178-1610
Version of Record valid from 2020-04-30